Assura, the UK-listed property business that designs and invests in key NHS buildings, has received an indicative, non-binding cash offer from a consortium consisting of private equity giant Kohlberg Kravis Roberts & Co (KKR) and Stonepeak Partners.
Should the private equity consortium pursue the cash offer, Assura shareholders would retain the declared quarterly dividend of 0.84p per share, due to be paid on 9 April, and receive a cash consideration of 48.56p per share at closing. This revised offer represents a 2.9% increase from KKR's previous indicative, non-binding proposal of 48p per share. Assura's share price jumps 12% after fourth KKR bid rejection The possible cash offer represents 100% of the company's EPRA net tangible asset value (NTA) of 49.4p per share at 30 September 2024, Assura said today (10 March) in a sto...
To continue reading this article...
Join Investment Week for free
Signup and gain exclusive members-only insights - all free of charge!
- Unlimited access to real-time news, analysis and opinion from the investment industry, including the Sustainable Hub covering fund news from the ESG space
- Get ahead of regulatory and technological changes affecting fund management
- Important and breaking news stories selected by the editors delivered straight to your inbox each day
- Weekly members-only newsletter with exclusive opinion pieces from leading industry experts
- Be the first to hear about our extensive events schedule and awards programmes
